The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
Copyright 2024 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.